WebMD Health (WBMD) Tops Q4 EPS by 6c, FY15 Revenue Guidance Falls Short

WebMD Health (NASDAQ: WBMD) reported Q4 EPS of $0.38, $0.06 better than the analyst estimate of $0.32. Revenue for the quarter came in at $162.7 million versus the consensus estimate of $160.84 million.

WebMD Health sees FY2015 revenue of $615-635 million, versus the consensus of $634.89 million.​

• Approximately $486 million to $502 million of revenue is expected to be from advertising and sponsorship, an increase of 7% to 11% from the prior year. Growth in advertising and sponsorship will be driven by growth in revenue from biopharma customers of approximately 12% to 15% in 2015.
• Approximately $105 million to $108 million of revenue is expected to be from private portals services, an increase of 2% to 5% from the prior year.
• Approximately $24 million to $25 million of revenue is expected to be from information services, an increase of 3% to 7% from the prior year.
• Adjusted EBITDA to be approximately $180 million to $190 million, an increase of approximately 13% to 20% from the prior year.
• Net income to be approximately $50.5 million to $59.5 million

For earnings history and earnings-related data on WebMD Health (WBMD) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Empire Petroleum posts $11.1M revenue in Q2 2026, narrows net loss
• Vivos Therapeutics (VVOS) Tops Q2 EPS by 6c